explore -WSS

explore

author：Wikipedia 2025-08-11 16:25:05 - browse：1

A gene-edited Yucatan minipig. -- health coverage from STAT — A gene-edited Yucatan minipig created by eGenesis. Courtesy Liz Linder/eGenesis

For three days in December, an ICU room at the Hospital of the University of Pennsylvania bore witness to the first-ever merging of two powerful new technologies poised to change the future of transplant medicine.

On a gurney, a brain-dead patient lay connected to a whirring Rube Goldberg-esque machine: a tangle of tubes and siphons on wheels. From a cannula on one end, blood from the patient entered, was pumped full of oxygen and other nutrients, then pushed into a cozy, temperature-controlled chamber containing a liver — one that until very recently had belonged to a CRISPR-edited pig — before being returned to the patient.

The experiment, designed to test whether a genetically engineered porcine liver kept alive in a box could support the circulatory system of a human, was a resounding success, the research team said Thursday.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Hepatitis C has a cure — but many Americans still lack access to it
Next article： AI gets buy

hotspot

WSS

Carvykti CAR

Global cancer cases to surge 77% by 2050, WHO report says

AI gets buy

340B reform proposal comes out of Senate working group

Grail spinoff by Illumina should end disastrous merger attempt

Padmanee Sharma of MD Anderson at center of lawsuit over credit

explore

explore

hotspot

Duchenne breakthrough therapy leaves behind pioneering families

Advocates call out 'SNL' over stereotypes, errors in sickle cell skit

Medicare details structure of new drug price negotiation program

How to keep neuroscience’s past racism from being its future

Trump demands the U.S. pay no more for drugs than other countries … again

SEC charges former device maker CEO with $41 million fraud

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Albert Bourla of Pfizer: worst biopharma CEO of 2023

Medicare proposal to cover medical devices draws a mixed reaction

A single Democrat is willing to weaken Medicare negotiation power

Wikipedia

Gritstone Bio's cancer vaccine test, and more on Novartis' deal

Readout Newsletter: The latest on Moderna, Apellis, and Merck

Cano Health’s bankruptcy is a warning for Medicare Advantage

AI gets buy

Adopting new red light myopia treatments may be short

Bristol Myers buys into radiopharmaceuticals with RayzeBio

hotspot

hotspot

knowledge

leisure time